Hanna Roetschke
Co-Founder and CTO, decyte
Dr Hanna Roetschke is co-founder and CTO of decyte, an early-stage TechBio startup leveraging data science for the early detection of immune-related diseases.
Operating at the intersection of biomedicine and data science, Hanna has established a track record in cutting-edge immuno-oncology research, created a new platform for interdisciplinary scientists. Building on that experience, she is now developing a fundamentally new approach for disease detection at decyte.
She earned her PhD from King’s College London and the Francis Crick Institute as one of the youngest graduates in the university’s history.